1. Efficacy and safety profile of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease. Issue 3 (3rd March 2020) Authors: Scheen, André J Journal: Expert opinion on drug safety Issue: Volume 19:Issue 3(2020) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment-related transient splenial lesion of the Corpus Callosum in patients with neuropsychiatric disorders: a literature overview with a case report. Issue 3 (3rd March 2020) Authors: Cirnigliaro, Giovanna; Di Bernardo, Ilaria; Caricasole, Valentina; Piccoli, Eleonora; Scaramelli, Barbara; Pomati, Simone; Villa, Chiara; Pantoni, Leonardo; Dell'Osso, Bernardo Journal: Expert opinion on drug safety Issue: Volume 19:Issue 3(2020) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Concerns about the safety of anti-TNF agents when treating rheumatic diseases. Issue 6 (2nd June 2020) Authors: Atzeni, Fabiola; Nucera, Valeria; Gerratana, Elisabetta; Cirillo, Mariateresa; Marino, Francesca; Miceli, Gianfranco; Sangari, Donatella; Boccassini, Laura; Masala, Ignazio Francesco Journal: Expert opinion on drug safety Issue: Volume 19:Issue 6(2020) Page Start: 695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Nothing is perfect: the safety issues of integrase inhibitor regimens. Issue 6 (2nd June 2020) Authors: Scévola, Sofía; Tiraboschi, Juan Manuel; Podzamczer, Daniel Journal: Expert opinion on drug safety Issue: Volume 19:Issue 6(2020) Page Start: 683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials. Issue 6 (2nd June 2020) Authors: Selvy, Marie; Cuménal, Mélissa; Kerckhove, Nicolas; Courteix, Christine; Busserolles, Jérôme; Balayssac, David Journal: Expert opinion on drug safety Issue: Volume 19:Issue 6(2020) Page Start: 707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A description of medicines-related safety issues evaluated through a referral procedure at the EU level after 2012. Issue 6 (2nd June 2020) Authors: Farcas, Andreea; Balcescu, Teodora; Anghel, Laura; Bucsa, Camelia; Mogoșan, Cristina Journal: Expert opinion on drug safety Issue: Volume 19:Issue 6(2020) Page Start: 755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system. Issue 7 (3rd July 2019) Authors: Aggarwal, Pushkar Journal: Expert opinion on drug safety Issue: Volume 18:Issue 7(2019) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysis. Issue 7 (3rd July 2019) Authors: Galati, Giovanni; Muley, Moises; Viganò, Mauro; Iavarone, Massimo; Vitale, Alessandro; Dell'Unto, Chiara; Lai, Quirino; Cabibbo, Giuseppe; Sacco, Rodolfo; Villa, Erica; Trevisani, Franco Journal: Expert opinion on drug safety Issue: Volume 18:Issue 7(2019) Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A comparative safety review of histone deacetylase inhibitors for the treatment of myeloma. Issue 7 (3rd July 2019) Authors: Cengiz Seval, Guldane; Beksac, Meral Journal: Expert opinion on drug safety Issue: Volume 18:Issue 7(2019) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity. Issue 7 (3rd July 2019) Authors: Bello, Nicholas T. Journal: Expert opinion on drug safety Issue: Volume 18:Issue 7(2019) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗